Then, we investigate LAPTM4B protein levels in 63 LAC tissues by IHC and our results revealed that high expression of LAPTM4B correlated with aggressive clinicopathological features (including advanced clinical stages, lymph node metastasis and EGFR mutations). The gene discussed is LAPTM4B; the disease is metastatic malignant neoplasm in the lymph nodes.